Legal Team Selected to Spearhead Ozempic Lawsuit Efforts
New York — A team of prominent lawyers has been appointed to spearhead the high-profile legal cases regarding the weight-loss drug Ozempic, signaling an escalation in the series of lawsuits filed against its manufacturer, Novo Nordisk. The litigation contends that Novo Nordisk failed to adequately warn users about significant, potentially hazardous side effects of the drug, widely used in the battle against obesity. Chosen for their expertise in pharmaceutical litigation, these attorneys are tasked with consolidating numerous claims that have emerged from various states across the country. This legal battle highlights the myriad challenges faced … Read more